Campagne O - Search Results

1

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.

Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Campagne O, Banerjee A, Gururangan S, Kilburn LB, Goldman S, Qaddoumi I, Baxter P, Vezina G, Bregman C, Patay Z, Jones JY, Stewart CF, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Among authors: campagne o. Neuro Oncol. 2021 Oct 1;23(10):1777-1788. doi: 10.1093/neuonc/noab047. Neuro Oncol. 2021. PMID: 33631016 Free PMC article. Clinical Trial.

2

CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors.

Patel YT, Davis A, Baker SJ, Campagne O, Stewart CF. Patel YT, et al. Among authors: campagne o. Cancer Chemother Pharmacol. 2019 Aug;84(2):447-452. doi: 10.1007/s00280-019-03864-9. Epub 2019 May 11. Cancer Chemother Pharmacol. 2019. PMID: 31079218 Free PMC article.

3

Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.

Reddick SJ, Campagne O, Huang J, Onar-Thomas A, Broniscer A, Gajjar A, Stewart CF. Reddick SJ, et al. Among authors: campagne o. Cancer Chemother Pharmacol. 2019 Oct;84(4):829-838. doi: 10.1007/s00280-019-03921-3. Epub 2019 Aug 7. Cancer Chemother Pharmacol. 2019. PMID: 31392390 Free PMC article. Clinical Trial.

4

An LC/ESI-MS/MS method to quantify the PI3K inhibitor GDC-0084 in human plasma and cerebrospinal fluid: Validation and clinical application.

Zhong B, Campagne O, Tinkle CL, Stewart CF. Zhong B, et al. Among authors: campagne o. Biomed Chromatogr. 2020 Jan;34(1):e4697. doi: 10.1002/bmc.4697. Epub 2019 Oct 21. Biomed Chromatogr. 2020. PMID: 31495945 Free PMC article.

5

Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours.

Panetta JC, Roberts JK, Huang J, Lin T, Daryani VM, Harstead KE, Patel YT, Onar-Thomas A, Campagne O, Ward DA, Broniscer A, Robinson G, Gajjar A, Stewart CF. Panetta JC, et al. Among authors: campagne o. Br J Clin Pharmacol. 2020 Feb;86(2):362-371. doi: 10.1111/bcp.14160. Epub 2020 Jan 8. Br J Clin Pharmacol. 2020. PMID: 31657864 Free PMC article.

6

CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model.

Campagne O, Davis A, Maharaj AR, Zhong B, Stripay J, Farmer D, Roussel MF, Stewart CF. Campagne O, et al. Eur J Pharm Sci. 2020 Jan 15;142:105106. doi: 10.1016/j.ejps.2019.105106. Epub 2019 Oct 25. Eur J Pharm Sci. 2020. PMID: 31669383 Free PMC article.

7

Exposure-Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing.

Campagne O, Zhong B, Nair S, Lin T, Huang J, Onar-Thomas A, Robinson G, Gajjar A, Stewart CF. Campagne O, et al. Clin Cancer Res. 2020 Apr 1;26(7):1563-1573. doi: 10.1158/1078-0432.CCR-19-2685. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796512 Free PMC article. Clinical Trial.

8

CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice.

Campagne O, Davis A, Zhong B, Nair S, Haberman V, T Patel Y, Janke L, F Roussel M, Stewart C. Campagne O, et al. J Pharm Pharm Sci. 2019;22(1):612-629. doi: 10.18433/jpps30608. J Pharm Pharm Sci. 2019. PMID: 31815662 Free PMC article.

9

Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.

Reddick SJ, Campagne O, Huang J, Onar-Thomas A, Broniscer A, Gajjar A, Stewart CF. Reddick SJ, et al. Among authors: campagne o. Cancer Chemother Pharmacol. 2020 Feb;85(2):475. doi: 10.1007/s00280-019-04026-7. Cancer Chemother Pharmacol. 2020. PMID: 31912224

10

A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors.

Santana VM, Sahr N, Tatevossian RG, Jia S, Campagne O, Sykes A, Stewart CF, Furman WL, McGregor LM. Santana VM, et al. Among authors: campagne o. Cancer. 2020 Apr 15;126(8):1749-1757. doi: 10.1002/cncr.32722. Epub 2020 Jan 22. Cancer. 2020. PMID: 31967673 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters